Literature DB >> 17509026

Aberrant DNA methylation in non-neoplastic gastric mucosa of H. Pylori infected patients and effect of eradication.

Francesco Perri1, Rosa Cotugno, Ada Piepoli, Antonio Merla, Michele Quitadamo, Annamaria Gentile, Alberto Pilotto, Vito Annese, Angelo Andriulli.   

Abstract

BACKGROUND: Gene promoter methylation is an epigenetic event leading to gene silencing. This mechanism is particularly relevant in cancer since it can interfere with the activity of specific "suppressor" genes. AIM: To evaluate promoter methylation of CDH1, p16, APC, MLH1, and COX2 in patients with H. pylori (Hp) infection before and after eradication.
METHODS: Fifty-seven dyspeptic outpatients who had never performed previous endoscopy or Hp testing and treatment underwent clinical interview, endoscopy with three paired gastric biopsy specimens from the antrum, angulus, and corpus, and (13)C-urea breath test (UBT). Biopsies were scored for the presence of Hp and intestinal metaplasia (IM). DNA methylation of five tumor-related genes (CDH1, p16, MLH1, APC, and COX2) was evaluated by methylation-specific PCR in each biopsy. Infected patients were given a standard eradicating treatment and, after 1 yr, underwent endoscopy with biopsies and UBT.
RESULTS: Hp infection was found in 45 patients. IM was detected in 17 out of 45 (38%) infected patients. Mean number of methylated genes was 0, 1.1 +/- 0.9, and 1.6 +/- 0.9 among the 12 Hp-/IM-, the 28 Hp+/IM-, and the 17 Hp+/IM+ patients, respectively (P < 0.0001). Specifically, promoter hypermethylation of CDH1, p16, APC, MLH1, and COX2 was found in 68%, 25%, 7%, 0%, and 14% of Hp+/IM- patients and in 71%, 29%, 35%, 12%, and 12% of Hp+/IM+ patients. No significant difference was found among the three groups of patients as far as age, smoking, alcohol, meat and vegetable consumption, and family history of gastric cancer were considered. Twenty-three out of 45 (51%) infected patients underwent the 1-yr follow-up endoscopy: 17 out of 23 (74%) were successfully eradicated. After Hp eradication, CDH1, p16, and APC methylation significantly decreased while COX2 methylation completely disappeared. Conversely, MLH1 methylation did not change significantly in patients with IM.
CONCLUSION: Hp infection is associated with promoter methylation of genes which are relevant in the initiation and progression of gastric carcinogenesis. While CDH1 methylation seems to be an early event in Hp gastritis, MLH1 methylation occurs late along with IM. Hp eradication is able to significantly reduce gene methylation thus delaying or reversing Hp-induced gastric carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17509026     DOI: 10.1111/j.1572-0241.2007.01284.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  67 in total

1.  Promoter DNA hypermethylation in gastric biopsies from subjects at high and low risk for gastric cancer.

Authors:  Barbara G Schneider; Dun-Fa Peng; M Constanza Camargo; M Blanca Piazuelo; Liviu A Sicinschi; Robertino Mera; Judith Romero-Gallo; Alberto G Delgado; Luis E Bravo; Keith T Wilson; Richard M Peek; Pelayo Correa; Wael El-Rifai
Journal:  Int J Cancer       Date:  2010-12-01       Impact factor: 7.396

Review 2.  Prospects for epigenetic epidemiology.

Authors:  Debra L Foley; Jeffrey M Craig; Ruth Morley; Craig A Olsson; Craig J Olsson; Terence Dwyer; Katherine Smith; Richard Saffery
Journal:  Am J Epidemiol       Date:  2009-01-12       Impact factor: 4.897

3.  Changing the natural history of metachronous gastric cancer after H. pylori eradication.

Authors:  David Y Graham; Satoko Matsueda; Akiko Shiotani
Journal:  Jpn J Helicobacter Res       Date:  2015

4.  Telomere length in non-neoplastic gastric mucosa and its relationship to H. pylori infection, degree of gastritis, and NSAID use.

Authors:  Tomomitsu Tahara; Tomoyuki Shibata; Tomohiko Kawamura; Takamitsu Ishizuka; Masaaki Okubo; Mitsuo Nagasaka; Yoshihito Nakagawa; Tomiyasu Arisawa; Naoki Ohmiya; Ichiro Hirata
Journal:  Clin Exp Med       Date:  2015-01-07       Impact factor: 3.984

Review 5.  How to stomach an epigenetic insult: the gastric cancer epigenome.

Authors:  Nisha Padmanabhan; Toshikazu Ushijima; Patrick Tan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-05-17       Impact factor: 46.802

6.  Helicobacter pylori and EBV in gastric carcinomas: methylation status and microsatellite instability.

Authors:  Adriana Camargo Ferrasi; Nídia Alice Pinheiro; Silvia Helena Barem Rabenhorst; Otávia Luisa Caballero; Maria Aparecida Marchesan Rodrigues; Fabrício de Carvalho; Celso Vieira de Souza Leite; Marcia Valéria Pitombeira Ferreira; Marcos Aurélio Pessoa Barros; Maria Inês Moura Campos Pardini
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

Review 7.  Promoter methylation in the genesis of gastrointestinal cancer.

Authors:  Clement Richard Boland; Sung Kwan Shin; Ajay Goel
Journal:  Yonsei Med J       Date:  2009-06-23       Impact factor: 2.759

Review 8.  Epigenetic modifications induced by Helicobacter pylori infection through a direct microbe-gastric epithelial cells cross-talk.

Authors:  Lorenzo Chiariotti; Tiziana Angrisano; Simona Keller; Ermanno Florio; Ornella Affinito; Pierlorenzo Pallante; Cinzia Perrino; Raffaela Pero; Francesca Lembo
Journal:  Med Microbiol Immunol       Date:  2013-05-29       Impact factor: 3.402

9.  MGMT and MLH1 methylation in Helicobacter pylori-infected children and adults.

Authors:  Marisa C Alvarez; Juliana C Santos; Nathália Maniezzo; Marcelo S Ladeira; Artur L C da Silva; Isabel C A Scaletsky; José Pedrazzoli; Marcelo L Ribeiro
Journal:  World J Gastroenterol       Date:  2013-05-28       Impact factor: 5.742

Review 10.  Helicobacter and gastric malignancies.

Authors:  António Carlos Ferreira; Hajime Isomoto; Masatsugu Moriyama; Toshio Fujioka; José Carlos Machado; Yoshio Yamaoka
Journal:  Helicobacter       Date:  2008-10       Impact factor: 5.753

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.